Literature DB >> 22287235

Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration.

Gema Méndez-Lagares1, Antonio García-Pergañeda, María del Mar del Pozo-Balado, Miguel Genebat, Ezequiel Ruiz-Mateos, María García García, María Ángeles Muñoz-Fernández, Yolanda María Pacheco, Manuel Leal.   

Abstract

OBJECTIVES: This study examined the homeostatic parameters possibly related to HIV-infected patients who, despite being under suppressive highly active antiretroviral therapy (HAART), show low-level CD4 T cell repopulation (LLR).
METHODS: Twenty-one LLR individuals, 20 HIV-infected controls with satisfactory CD4 T cell repopulation (R) and 14 healthy subjects were studied. Markers related to activation, senescence and proliferation were analysed for both the CD4 and CD8 T cell subsets. Additionally, soluble CD14 (sCD14) and high-sensitivity C-reactive protein (hsCRP) were measured, and the CD34+ cells and the levels of interleukin-7 (IL-7) receptor were quantified.
RESULTS: The frequency of naive CD4 T cells from LLR patients was significantly reduced, and these cells showed increased expression of markers for activation, senescence and proliferation as compared with naive CD4 T cells from R patients. Naive CD8 T cells were also reduced when compared with those from R patients, but did not exhibit an altered phenotype. Moreover, frequencies of effector memory T cells were higher in LLR than R patients. No differences between LLR and R patients were observed for sCD14 levels, CD34+ cells and the IL-7 receptor, although LLR patients showed a tendency toward increased levels of hsCRP >2 μg/mL.
CONCLUSIONS: Patients with low CD4 T cell restoration under suppressive HAART show significant alterations in T cell homeostasis that do not appear to be related to a reduction in haematopoietic progenitors. sCD14 levels were not specifically altered in these patients. Our results agree with our previously proposed model of premature immunosenescence in LLR patients and further describe homeostatic features associated with poor CD4 recovery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287235     DOI: 10.1093/jac/dkr594

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort.

Authors:  Meghan E Fitzpatrick; Vikas Singh; Marnie Bertolet; Lorrie Lucht; Cathy Kessinger; Joshua Michel; Alison Logar; Renee Weinman; Deborah McMahon; Karen A Norris; Abbe N Vallejo; Alison Morris
Journal:  AIDS       Date:  2014-11-13       Impact factor: 4.177

2.  Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation.

Authors:  Thibaut Davy-Mendez; Sonia Napravnik; Oksana Zakharova; JoAnn Kuruc; Cynthia Gay; Charles B Hicks; Kara S Mcgee; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

3.  Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.

Authors:  J Saison; T Ferry; J Demaret; D Maucort Boulch; F Venet; T Perpoint; F Ader; V Icard; C Chidiac; G Monneret
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

4.  Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach.

Authors:  Roksana Karim; Wendy J Mack; Tracey Stiller; Eva Operskalski; Toni Frederick; Alan Landay; Mary A Young; Phyllis C Tien; Mike Augenbraun; Howard D Strickler; Andrea Kovacs
Journal:  AIDS       Date:  2013-06-01       Impact factor: 4.177

5.  Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells.

Authors:  Wouter A van der Heijden; Lisa Van de Wijer; Farid Keramati; Wim Trypsteen; Sofie Rutsaert; Rob Ter Horst; Martin Jaeger; Hans Jpm Koenen; Hendrik G Stunnenberg; Irma Joosten; Paul E Verweij; Jan van Lunzen; Charles A Dinarello; Leo Ab Joosten; Linos Vandekerckhove; Mihai G Netea; André Jam van der Ven; Quirijn de Mast
Journal:  JCI Insight       Date:  2021-04-08

6.  Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.

Authors:  Marta Massanella; Elisabet Gómez-Mora; Jorge Carrillo; Marta Curriu; Dan Ouchi; Jordi Puig; Eugènia Negredo; Cecilia Cabrera; Bonaventura Clotet; Julià Blanco
Journal:  J Transl Med       Date:  2015-07-17       Impact factor: 5.531

7.  Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.

Authors:  Victor Leung; Jennifer Gillis; Janet Raboud; Curtis Cooper; Robert S Hogg; Mona R Loutfy; Nima Machouf; Julio S G Montaner; Sean B Rourke; Chris Tsoukas; Marina B Klein
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

8.  P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ART.

Authors:  Inna Menkova-Garnier; Hakim Hocini; Emile Foucat; Pascaline Tisserand; Laure Bourdery; Constance Delaugerre; Clarisse Benne; Yves Lévy; Jean-Daniel Lelièvre
Journal:  PLoS Pathog       Date:  2016-04-15       Impact factor: 6.823

9.  Systemic Cytokine Levels Do Not Predict CD4(+) T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection.

Authors:  Philip J Norris; Jinbing Zhang; Andrew Worlock; Sangeetha V Nair; Kathryn Anastos; Howard L Minkoff; Maria C Villacres; Mary Young; Ruth M Greenblatt; Seema Desai; Alan L Landay; Stephen J Gange; C Thomas Nugent; Elizabeth T Golub; Sheila M Keating
Journal:  Open Forum Infect Dis       Date:  2016-02-08       Impact factor: 3.835

10.  Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study.

Authors:  Oscar Okwudiri Onyema; Lore Decoster; Rose Njemini; Louis Nuvagah Forti; Ivan Bautmans; Marc De Waele; Tony Mets
Journal:  BMC Cancer       Date:  2015-12-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.